Novonesis Statistics
Total Valuation
Novonesis has a market cap or net worth of 26.43 billion. The enterprise value is 28.23 billion.
Market Cap | 26.43B |
Enterprise Value | 28.23B |
Important Dates
The next estimated earnings date is Wednesday, February 26, 2025.
Earnings Date | Feb 26, 2025 |
Ex-Dividend Date | Aug 30, 2024 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.26% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 345.19M |
Valuation Ratios
The trailing PE ratio is 87.23.
PE Ratio | 87.23 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 33.32 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.73, with an EV/FCF ratio of 41.72.
EV / Earnings | 93.16 |
EV / Sales | 8.92 |
EV / EBITDA | 34.73 |
EV / EBIT | 52.06 |
EV / FCF | 41.72 |
Financial Position
The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.18.
Current Ratio | 1.11 |
Quick Ratio | 0.67 |
Debt / Equity | 0.18 |
Debt / EBITDA | 2.53 |
Debt / FCF | 3.15 |
Interest Coverage | 11.54 |
Financial Efficiency
Return on equity (ROE) is 4.38% and return on invested capital (ROIC) is 4.12%.
Return on Equity (ROE) | 4.38% |
Return on Assets (ROA) | 3.45% |
Return on Capital (ROIC) | 4.12% |
Revenue Per Employee | 312,121 |
Profits Per Employee | 28,990 |
Employee Count | 6,756 |
Asset Turnover | 0.32 |
Inventory Turnover | 2.66 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.29% in the last 52 weeks. The beta is 0.52, so Novonesis's price volatility has been lower than the market average.
Beta (5Y) | 0.52 |
52-Week Price Change | +12.29% |
50-Day Moving Average | 59.66 |
200-Day Moving Average | 61.28 |
Relative Strength Index (RSI) | 36.92 |
Average Volume (20 Days) | 841 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novonesis had revenue of 3.26 billion and earned 303.00 million in profits. Earnings per share was 1.09.
Revenue | 3.26B |
Gross Profit | 1.52B |
Operating Income | 562.57M |
Pretax Income | 393.62M |
Net Income | 303.00M |
EBITDA | 714.95M |
EBIT | 562.57M |
Earnings Per Share (EPS) | 1.09 |
Balance Sheet
The company has 279.44 million in cash and 2.13 billion in debt, giving a net cash position of -1.85 billion.
Cash & Cash Equivalents | 279.44M |
Total Debt | 2.13B |
Net Cash | -1.85B |
Net Cash Per Share | n/a |
Equity (Book Value) | 11.79B |
Book Value Per Share | 42.42 |
Working Capital | 189.65M |
Cash Flow
In the last 12 months, operating cash flow was 954.62 million and capital expenditures -277.95 million, giving a free cash flow of 676.67 million.
Operating Cash Flow | 954.62M |
Capital Expenditures | -277.95M |
Free Cash Flow | 676.67M |
FCF Per Share | n/a |
Margins
Gross margin is 46.66%, with operating and profit margins of 17.24% and 9.29%.
Gross Margin | 46.66% |
Operating Margin | 17.24% |
Pretax Margin | 12.07% |
Profit Margin | 9.29% |
EBITDA Margin | 21.92% |
EBIT Margin | 17.24% |
FCF Margin | 20.74% |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 0.50%.
Dividend Per Share | 0.30 |
Dividend Yield | 0.50% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 99.19% |
Buyback Yield | 0.26% |
Shareholder Yield | 0.76% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Novonesis has an Altman Z-Score of 3.78.
Altman Z-Score | 3.78 |
Piotroski F-Score | n/a |